LENZ Earnings

Quarterly EPS
$-0.38
Q3 2024
$-0.45
Q4 2024
$-0.53
Q1 2025
$-0.53
Q2 2025
$-0.59
Q3 2025
$-1.15
Q4 2025
$-1.32
Q1 2026
$-1.02
Q2 2026
Latest Revenue5.5M
Latest Net Income-31918000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.025.5M-31918000+9.7%-92.5%
Q1 2026-$1.321.9M-41488000-149.1%
Q4 2025-$1.151.6M-35896000-155.6%
Q3 2025-$0.5912.5M-16700000-55.3%
Q2 2025-$0.535.0M-14912000-32.5%
Q1 2025-$0.530-14619000+85.0%
Q4 2024-$0.450-12652000
Q3 2024-$0.380-10215000
Q2 2024-$0.400-10254000
Q1 2024-$3.530-16648000
LENZ Therapeutics (LENZ) — Earnings